Saakshi Medtech and Panels (SAAKSHI) Stock Overview
Engages in the manufacture and sale of electrical control panels and cabinets in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
SAAKSHI Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
America Wants Homegrown Drones — Draganfly Is Ready to Deliver
Key Takeaways Draganfly is one of the most experienced drone manufacturers worldwide, boasting nearly three decades of innovation, and is now emerging as a North American leader in secure, NDAA-compliant drones. The company is riding massive industry tailwinds as Western governments shift away from Chinese-made drones, funneling billions into trusted domestic suppliers.
Saakshi Medtech and Panels Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹172.00 |
| 52 Week High | ₹255.00 |
| 52 Week Low | ₹118.00 |
| Beta | 0 |
| 1 Month Change | 1.78% |
| 3 Month Change | -17.57% |
| 1 Year Change | -25.59% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 12.20% |
Recent News & Updates
Saakshi Medtech and Panels (NSE:SAAKSHI) Might Be Having Difficulty Using Its Capital Effectively
Sep 16
Saakshi Medtech and Panels Limited (NSE:SAAKSHI) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Jun 27Recent updates
Saakshi Medtech and Panels (NSE:SAAKSHI) Might Be Having Difficulty Using Its Capital Effectively
Sep 16Saakshi Medtech and Panels Limited (NSE:SAAKSHI) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Jun 27We Think Saakshi Medtech and Panels (NSE:SAAKSHI) Is Taking Some Risk With Its Debt
Mar 29Saakshi Medtech and Panels' (NSE:SAAKSHI) Problems Go Beyond Weak Profit
Nov 21Be Wary Of Saakshi Medtech and Panels (NSE:SAAKSHI) And Its Returns On Capital
Nov 15Saakshi Medtech and Panels Limited (NSE:SAAKSHI) Looks Just Right With A 32% Price Jump
Jun 26These 4 Measures Indicate That Saakshi Medtech and Panels (NSE:SAAKSHI) Is Using Debt Extensively
Jun 22Shareholder Returns
| SAAKSHI | IN Electrical | IN Market | |
|---|---|---|---|
| 7D | -3.9% | 0.6% | 1.5% |
| 1Y | -25.6% | -9.0% | -4.7% |
Return vs Industry: SAAKSHI underperformed the Indian Electrical industry which returned -9% over the past year.
Return vs Market: SAAKSHI underperformed the Indian Market which returned -4.7% over the past year.
Price Volatility
| SAAKSHI volatility | |
|---|---|
| SAAKSHI Average Weekly Movement | 5.4% |
| Electrical Industry Average Movement | 5.0% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in IN Market | 8.3% |
| 10% least volatile stocks in IN Market | 3.2% |
Stable Share Price: SAAKSHI has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: SAAKSHI's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 119 | Aniket Latkar | www.smtpl.co |
Saakshi Medtech and Panels Limited engages in the manufacture and sale of electrical control panels and cabinets in India. It offers micro controllers, programmable logic controllers, and supervisory control and data acquisition systems used in elevators, air compressors, renewal energy industry, oil and gas exploration industry, electrical vehicle charging stations, etc. The company also provides medical X-ray systems, including X-ray machines, imaging systems, generators, and mechanical components for healthcare industry. In addition, it is involved in the locomotive fabrication works, which include sensor boxes, battery boxes, sand boxes, dynamic brake weldments, resistor boxes, oil tank assemblies, and snow plows for transportation infrastructure operation.
Saakshi Medtech and Panels Limited Fundamentals Summary
| SAAKSHI fundamental statistics | |
|---|---|
| Market cap | ₹3.04b |
| Earnings (TTM) | ₹47.10m |
| Revenue (TTM) | ₹924.31m |
Is SAAKSHI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SAAKSHI income statement (TTM) | |
|---|---|
| Revenue | ₹924.31m |
| Cost of Revenue | ₹579.53m |
| Gross Profit | ₹344.78m |
| Other Expenses | ₹297.68m |
| Earnings | ₹47.10m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.67 |
| Gross Margin | 37.30% |
| Net Profit Margin | 5.10% |
| Debt/Equity Ratio | 18.2% |
How did SAAKSHI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/04 19:57 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Saakshi Medtech and Panels Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.